Literature DB >> 21889551

Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli.

Alessandra Stefan1, Matteo Conti, Diego Rubboli, Lorenzo Ravagli, Enrica Presta, Alejandro Hochkoeppler.   

Abstract

The expression of the recombinant diphtheria toxin mutant CRM197 in bacteria other than Corynebacterium diphtheriae has proven to be difficult. Here we propose a new and alternative procedure for the production of full-length CRM197 in Escherichia coli. The present study relates specifically to the expression of an artificial sequence and to a method for the isolation and purification of the corresponding protein. In particular, a synthetic gene coding for CRM197, bearing a short histidine tag and optimized for E. coli codon usage, was cloned in the pET9a vector. Accordingly, the over-expression of the protein was simply induced with arabinose in E. coli BL21AI. The recombinant protein was insoluble and always found inside protein aggregates, which were solubilised using urea. Surprisingly, the expression of CRM197, devoid of the short tag, always failed. Following a refolding step, the his-tagged CRM197 was purified by affinity and gel-filtration chromatography and the purity of the final preparation reached 95%. Interestingly, the recombinant protein features DNase activity, indicating that the presence of the tag is not affecting its biochemical properties. However, the removal of the synthetic tag could be easily obtained by incubating the target protein with a proper quantity of a commercial enterokinase.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889551     DOI: 10.1016/j.jbiotec.2011.08.024

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  10 in total

1.  The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197.

Authors:  Pengdi Chai; Xiuying Pu; Jun Ge; Sulin Ren; Xiaoyu Xia; Amiao Luo; Shiwei Wang; Xiaodong Wang; Jianqiang Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-29       Impact factor: 4.813

2.  Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.

Authors:  Naphatsamon Uthailak; Pornpimol Mahamad; Pamorn Chittavanich; Somchai Yanarojana; Wassana Wijagkanalan; Jean Petre; Watanalai Panbangred
Journal:  Mol Biotechnol       Date:  2017-05       Impact factor: 2.695

3.  Immune response to Vi-antigen of Salmonella typhi is dependent on introduction of positive charge and shape of charged group into polysaccharide.

Authors:  A V Kolesnikov; A V Kozyr; A K Ryabko; I G Shemyakin; I A Dyatlov
Journal:  Dokl Biochem Biophys       Date:  2017-05-17       Impact factor: 0.788

4.  Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine.

Authors:  Neus Ferrer-Miralles; José Luis Corchero; Pradeep Kumar; Juan A Cedano; Kailash C Gupta; Antonio Villaverde; Esther Vazquez
Journal:  Microb Cell Fact       Date:  2011-12-02       Impact factor: 5.328

5.  Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines.

Authors:  Ravi P N Mishra; Ravi S P Yadav; Christopher Jones; Salvatore Nocadello; George Minasov; Ludmilla A Shuvalova; Wayne F Anderson; Akshay Goel
Journal:  Biosci Rep       Date:  2018-09-25       Impact factor: 3.840

6.  Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli.

Authors:  Ah-Reum Park; Seung-Won Jang; Jin-Sook Kim; Young-Gyun Park; Bong-Seong Koo; Hyeon-Cheol Lee
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

Review 7.  Recent advances in the production of recombinant glycoconjugate vaccines.

Authors:  Emily Kay; Jon Cuccui; Brendan W Wren
Journal:  NPJ Vaccines       Date:  2019-05-01       Impact factor: 7.344

8.  On-demand biomanufacturing of protective conjugate vaccines.

Authors:  Jessica C Stark; Thapakorn Jaroentomeechai; Tyler D Moeller; Jasmine M Hershewe; Katherine F Warfel; Bridget S Moricz; Anthony M Martini; Rachel S Dubner; Karen J Hsu; Taylor C Stevenson; Bradley D Jones; Matthew P DeLisa; Michael C Jewett
Journal:  Sci Adv       Date:  2021-02-03       Impact factor: 14.136

9.  Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.

Authors:  Shaimaa Abulmagd; Abd El-Nasser A Khattab; Hamdallah Zedan
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

10.  Comprehensive vaccine design for commensal disease progression.

Authors:  Charles H Jones; Guojian Zhang; Roozbeh Nayerhoda; Marie Beitelshees; Andrew Hill; Pooya Rostami; Yi Li; Bruce A Davidson; Paul Knight; Blaine A Pfeifer
Journal:  Sci Adv       Date:  2017-10-18       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.